The comparison of results that are numerically dependent on the procedure employed continues to present significant problems in clinical biochemistry. The range of method-specific reference ranges associated with individual methods restricts access to the database available in the scientific literature, they cause inconvenience when patients move between practitioners whose data are supplied by laboratories employing different methods, and in the worst case may result in clinical misinterpretation of laboratory findings. Method-dependent results also present the organizers of external quality assessment (EQA) schemes with problems: are the different mean values of various method groups each equally valid estimates of the concentration of the analyte in the survey sample, or do they reflect differences in the specificity or bias of the various methods, and do the often large variations within a method group correspond to poor analytical performance within that group, or to heterogeneity of the methods included in the group.
The problem of method-dependent results has been recognized most clearly in the measurement of enzymes in terms of the catalysed rate of reaction. Here, method-dependence derives from the large range of variables-pH and nature of the buffers, temperature, presence of activators or inhibitors, substrate concentration and in some cases its nature-which, together with the amount of active enzyme present, influence the reaction rate. However, it is less well appreciated that an even larger category of results, those obtained by immunoassay, are also methoddependent, though in this case, method-dependency mainly derives from the varying, often illdefined specificities of antisera purporting to measure the same target analyte and from the use of different calibrators. In both enzyme rate This article was prepared under the auspices of the Analytical Investigations Standing Committee of the Scientific Committee of the Association of Clinical Biochemists. assays and immunoassays, ways of expressing the results have tended to obscure their methoddependency: in the former case by the use of a uniform system of expressing rate of change, the (international) unit, which may convey an impression of an absolute quantity, and in the latter by the reporting of results in units of mass concentration.
The term standardization has two meanings: to achieve a uniform standard of practice; or to compare with a standard of known or defined properties. The first can be equated with the use of uniform, agreed methodology; the second with the use of a common calibrator in methods which are themselves different.
The use of a single, agreed procedure for each enzyme of clinical interest has been the goal of national and international bodies concerned with clinical enzymology for more than a quarter of a century. The successes of this 'recommended method' approach should not be underestimated. Recommended methods have focused attention on the shortcomings of many previously used methods and have raised the level of expectation of users with regard to standards of precision and freedom from bias that can be provided by enzyme measurements. Some recommended methods have gained wide acceptance. For instance, 80% of laboratories in the UK NEQAS for clinical chemistry use the European/IFCC recommended method for creatine kinase measurement with levels of interlaboratory agreement that are regularly below 10% coefficient of variation, equal to those expected for non-enzyme analytes. However, it now seems clear that the goal of a single, universally used method for measuring the catalytic concentration of a given enzyme will not be achieved, even within the boundaries of a single country. Several factors can account for this.
Development and improvement are essential characteristics ofanalytical methodology, leading to constant modification of methods. Recommended methods are slow to respond to these advances, and so are often seen as irrelevant to up-to-date practice. The constant pressure of technical improvement is the most important single factor militating against the universal adoption of recommended methods. Recommended methods themselves become corrupted, either inadvertently, through misinterpretation, or deliberately to accommodate the limitations imposed by automated instrumentation or to meet production needs for prepackaged reagent kits. Furthermore, the inability of national and international commissions to agree on specific procedures must be admitted as a factor justifying reluctance to adopt recommended methods. Even though the differences between recommendation are often small, the consequent lack of a clear advantage of one method over another provides no incentive for users to adopt a particular recommendation. Alkaline phosphatase methods provide an example of this. In UK NEQAS, choice of methods is almost equally divided between the SCE/German recommendations with diethanolamine buffer, and IFCCjACCC-based methods with aminopropanol buffer. Although the inter-group mean values differ by a factor of approximately two, there is no difference between the groups with regard to intra-group agreement; in both cases, performance within the respective method group is excellent, with neither demonstrating an advantage over the other.
The wider use of well-proven recommended methods is not to be discouraged: nevertheless, a new approach is needed to reduce further the possibilities for error inherent in the use of method-dependent results. This could be found in a critical assessment of the use of calibrators common to several methods. It should be acknowledged at once that the use of a calibrator to predict or imply that a given enzyme sample would have a certain activity within an assay system that was not, in fact, used is a compromise that is not in accordance with strict metrological principles: these principles would insist that a kind of quantity such as catalytic activity is defined by a particular set of conditions, and is inseparable from it. However, careful choices in the use of an inter-method calibrator can avoid adverse practical consequences of this compromise.
CRITERIA FOR SELECTING METHODS AND CALIBRATORS!
The calibrated (routine) method and the calibrating (reference) method must have identical, or at least closely similar, specificities for the Ann Clin Biochem 1997: 34 analyte. Where the analyte is an enzyme, this requires, among more general factors, similar selectivities towards individual isoenzymes: e.g., commutability should not be expected between two methods for measuring the catalytic concentrations of acid phosphatase in serum that have differing selectivities for prostatic and nonprostatic isoenzymes. The chosen method should be equally insensitive to sample-dependent, enzymic or non-enzymic side-reactions.
A second essential is that the properties of the enzyme calibrator should be as similar as possible to those typical of the analyte enzyme in its natural matrix, usually human serum or plasma. In other words, the ratio between the routine and reference methods found for the calibrator must be the same as the average ratio found for a large number of patients' samples.
In principle, this is most easily achieved by adding the relevant human (iso)enzyme to a human serum or plasma pool. In practice, the supply of human enzyme is complicated by ethical and hygienic considerations, while the presence of a basal level of the analyte (iso)enzyme and other, uncontrolled reactivities are further complications in selecting a serum or plasma matrix. However, enzymes from animal tissues or from genetically-engineered cells can closely mimic the properties of their human analogues and, since the protein content and ionic composition seem to be the most important features of the enzyme-containing matrix, the use of appropriately chosen non-human enzymes and synthetic matrices does not invalidate enzyme calibration materials in many cases.
The third criterion for successful calibration of a routine method in terms of a reference method is that the ratio between the two methods should be constant (within the limits of experimental error) for every patient's sample. No unequivocal guarantee can be given that this will be so. However, the probability that a sample-independent inter-method ratio exists is increased by careful choices of methods and calibrators, and can be further increased by extending the number and range of samples for which the ratio is experimentally determined by the two methods.
The concept of a constant inter-method ratio for all samples, including the calibrator and all patients' samples, has been described by the term 'comrnutability'. Commutability was originally introduced to describe a property of a reference material. However, a recent definition (Dybkaer R, personal communication) extends the scope to patients' samples:
Commutability: ability of a material to yield the same numerical relationship between results of measurements by a given set of measurement procedures, purporting to measure the same measurable quantity, as the expectation of the relationship obtained when the same procedures are applied to other relevant types of material.
Commutability of a material refers to a given set of measurement procedures. The set comprises at least two different procedures. Typically, the 'material' under consideration is a reference material containing the component of the measurable quantity, and 'other relevant types of material' include a large number of samples from healthy subjects and from patients with diseases known to affect the concentration or speciation of the component or matrix properties.
The acceptable variation of the inter-method ratio that is considered to be within the limits of experimental error and therefore consistent with the absence of a sample-dependent variation depends on the characteristics of the routine and reference methods. Some variation about the regression line relating results given by the routine method to those obtained by the reference method, when applied to the same samples, is inevitable because each method has its own inherent imprecision. To determine whether the distribution of experimental points about the regression line arises solely from the imprecision of the respective methods, or whether there is, in addition, a sample-dependent variation-i.e., the requirement for commutability between calibrant and sample in one or both methods is not met---can be approached statistically. Equations for predicting the variation of the inter-method ratio due to the known imprecisions of the respective methods and other statistical techniques are available.? These can be used to compare the predicted sample-independent variation of the inter-method ratio with that observed when a sufficiently large number of samples are analysed by each of the two methods. An alternative pragmatic approach is to determine, in such a series of samples, that some arbitrarily-chosen limit of variation is not exceeded. For example, a coefficient of variation
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of the inter-method ratio of the order of ±2'5% about the mean for a large number of patients' samples has been suggested but this may be unnecessarily rigorous for some methods and applications. ' The process of establishing that an acceptable degree of commutability exists between the samples and calibrator in a routine method and a reference method thus requires a combination of theory and practice. First, the choice of methods similar in analytical principles and, above all, in specificity for the analyte have to be determined. Second, an experimental demonstration is required showing the similarity of their relative analytical response in the two methods for both the calibration material and a number of patients' samples that is large enough to give a significant probability that subsequent samples will conform to the observed ratio. Ideally, the number of samples would be infinitely large. In practice, the number will be at least 50 and preferably 100 or more, covering a wide range of analytical concentrations and relevant underlying diseases.
THE WAY FORWARD
The method-dependence of results obtained from determinations of the catalytic concentrations of enzymes continues to present problems in clinical laboratory medicine, not only in the comparison of results of individual patients investigated in different laboratories but also in the assessment of EQA surveys. It is unlikely, and indeed undesirable, that the development of analytical clinical biochemistry can be frozen into a state in which only one method is accepted and used for each analyte.
The prospect of improved comparability of method-dependent results must lie with the inter-method conversion of results through the use of common calibrators. The benefits of this approach have already been demonstrated in a number of enzyme surveys.v? A survey of the use of the reference material CRM 319 for )1glutamyltransferase as a common calibrator in nine European laboratories showed excellent commutability, although 10 different assays of this enzyme were in use (Moss DW, unpublished). The time is thus ripe for expansion of the use of enzyme reference materials as intermethod calibrators: an effort that should engage the same levels of collaborative effort and experimental rigour that were deployed in support of the recommended-method approach in the field of clinical enzymology.
The use of common calibrators will undoubtedly involve some compromises and fall short of an ideal solution. Nevertheless, such compromises need not be at the expense of analytical quality, provided the criteria for acceptable inter-method commutability are defined and observed.
